ArticleDiseases (Basel, Switzerland)2025

Real-World Efficacy and Safety of Dupilumab Use in Japanese Adult Patients with Atopic Dermatitis: A Single-Center, Retrospective, 104-Week, Observational Study.

Tetsuharu Ikegami et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.